Resido Medical is categorized under Transcutaneous Electrical Nerve Stimulators (Tens) in San Francisco, CA and active since 2013.
Resido Medical was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Transcutaneous Electrical Nerve Stimulators (Tens) business, which does work in the B2B market, and is classified as a Transcutaneous Electrical Nerve Stimulators (Tens), under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Kathryn Rosenbluth at the company’s single location by writing to 43 Nordhoff St, San Francisco, California CA 94131 or by phoning (650) 387-6065. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Resido Medical |
| Contact Person: | Kathryn Rosenbluth |
| Address: | 43 Nordhoff St, San Francisco, California 94131 |
| Phone Number: | (650) 387-6065 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Transcutaneous Electrical Nerve Stimulators (Tens) |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Resido Medical was started in 2013 to provide professional Transcutaneous Electrical Nerve Stimulators (Tens) under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kathryn Rosenbluth for inquiries that concern Resido Medical by calling the company number (650) 387-6065, as your correspondence is most welcome. Additionally, the physical location of the single location of Resido Medical can be found at the coordinates 37.733709,-122.441071 as well as the street address 43 Nordhoff St in San Francisco, California 94131.
For its online presence, you may visit Resido Medical’s website at and engage with its social media outlets through on Twitter and on Facebook.